Funded Tech Companies
Kinvard Bio
Kinvard Bio, operating out of Raleigh, received equity investments from Carb-X.
Company Overview
Company Name
Kinvard Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Raleigh, NC Undisclosed
USA
Raleigh, NC Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Kinvard Bio, a spin-out from the prestigious Myers Lab at Harvard University's Department of Chemistry and Chemical Biology, is pioneering the development of a new and differentiated class of ribosome-targeting antibacterials known as oxepanoprolinamides (OPPs). With a focus on addressing the highest unmet patient need and commercial potential, Kinvard Bio's OPP class of antibacterials presents substantial therapeutic potential across multiple clinical indications.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/29/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lloyd Payne
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs